What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2017-09-13 compared with 2016-02-18 · 77 added, 34 removed, 2 unchanged (98% of the section changed)

OTHER INFORMATION

In reviewing the agreements included as exhibits to this Form 10-Q, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements.

The agreements may contain representations and warranties by each of the parties to the applicable agreement.

These representations and warranties have been made solely for the benefit of the parties to the applicable agreement and:

should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;

have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;

may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors;

were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time.

Additional information about the Company may be found elsewhere in this Form 10-Q and the Companys other public filings, which are available without charge through the SECs website at http://www.sec.gov.

The following exhibits are included as part of this report:

Certification of Principal Executive Officer pursuant to Section 302 the Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer pursuant to Section 302 the Sarbanes-Oxley Act of 2002

Certification of Chief Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Certification of Chief Financial Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SCH XBRL Schema Document

INS XBRL Instance Document

CAL XBRL Taxonomy Extension Calculation Linkbase Document

LAB XBRL Taxonomy Extension Label Linkbase Document

PRE XBRL Taxonomy Extension Presentation Linkbase Document

DEF XBRL Taxonomy Extension Definition Linkbase Document

________________

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Peak Pharmaceuticals, Inc.

February 18, 2016

/s/ Arnold Tinter

Arnold Tinter

Chief Executive Officer

Plan of acquisition, reorganization, arrangement, liquidation or

Articles of Merger

(incorporated by reference to our Registration Statement on Form

8-K filed on September 5, 2013)

Agreement and Plan

of Merger (incorporated by reference to our Registration Statement

on Form 8-K filed on September 5, 2013)

Articles of Merger

(incorporated by reference to our Registration Statement on Form

8-K filed on March 20, 2014)

Agreement and Plan

of Merger (incorporated by reference to our Registration Statement

on Form 8-K filed on March 20, 2014)

Articles of Merger

(incorporated by reference to our Registration Statement on Form

8-K filed on December 30, 2014)

Agreement and Plan

of Merger (incorporated by reference to our Registration Statement

on Form 8-K filed on December 30, 2014)

(i) Articles of Incorporation;

and (ii) Bylaws

Incorporation (incorporated by reference to our Registration

Statement on Form S-1 filed on December 29, 2008)

Certificate of

Amendment to Articles of Incorporation (incorporated by reference

to our Registration Statement on Form 10-K filed on December 26,

Certificate of

Change (incorporated by reference to our Registration Statement on

Form 10-K filed on December 26, 2012)

(incorporated by reference to our Registration Statement on Form

S-1 filed on December 29, 2008)

Instruments Defining the Rights of Security Holders, Including

Specimen Common

Stock Certificate (incorporated by reference to our Registration

Statement on Form S-1 filed on December 29, 2008)

of Registrant’s 10% Senior Convertible Promissory Note

(incorporated by reference to our Registration Statement on Form

8-K filed on October 17, 2013)

Material Contracts

Promissory Note dated March 21, 2017 with Trius Holdings Limited

(incorporated by reference to our Registrant’s Quarterly

Report on Form 10-Q filed on March 31, 2016.)

Promissory Note dated March 30, 2017 with Sukh Athwal (incorporated

by reference to our Registrant’s Quarterly Report on Form

10-Q filed on March 31, 2016.)

Rule 13a-14(a)/15d-14(a) Certification

Certification under the Sarbanes-Oxley Act of 2002 of the Principal

Executive Officer

Certification under the Sarbanes-Oxley Act of 2002 of the Principal

Financial Officer and Principal Accounting Officer

Section 1350 Certification

Certification under the Sarbanes-Oxley Act of 2002 of the Principal

Executive Officer

Certification under the Sarbanes-Oxley Act of 2002 of the Principal

Financial Officer and Principal Accounting Officer

Interactive Data Files

Instance Document

Taxonomy Extension Schema Document

Taxonomy Extension Calculation Linkbase Document

Taxonomy Extension Definition Linkbase Document

Taxonomy Extension Label Linkbase Document

Taxonomy Extension Presentation Linkbase Document

Filed herewith.

Furnished herewith.

Pursuant to Rule 406T of Regulation S-T, the

Interactive Data Files on Exhibit 101 hereto are deemed not filed

or part of any registration statement or prospectus for purposes of

Sections 11 or 12 of the Securities Act of 1933, are deemed not

filed for purposes of Section 18 of the Securities and Exchange Act

of 1934, and otherwise are not subject to liability under those

to the requirements of the Securities Exchange Act of 1934, the

registrant has duly caused this report to be signed on its behalf

by the undersigned, thereunto duly authorized.

PEAK PHARMACEUTICALS, INC.

February 18, 2016

/s/ Arnold Tinter

Arnold Tinter

Chief Financial Officer

Neil Reithinger

Executive Officer and Chief Financial Officer (Principal Executive

Officer, Principal Financial Officer and Principal Accounting

September 12, 2017

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information